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Purpose  
To assess the changes in diabetic retinopathy (DR) in type 2 diabetes (T2DM) patients post bariatric 
surgery and report on the risk factors that may be associated with it.  
Method 
Retrospective observational study of T2DM patients who underwent bariatric surgery in a UK 
specialist bariatric unit between 2009 and 2015. Pre-operative and post-operative weight, HbA1c 
and annual DRSS screening results were collected from medical records. Patients with pre-operative 
retinal screening and at least one post-operative retinal screening were eligible for analysis. 
Multivariate analysis was used to explore significant clinical predictors on post-operative worsening 
in DR, controlling for important baseline characteristics.  
Results 
102 patients were eligible for analysis and were followed up for 4 years. Pre-operatively, 68% of 
patients had no DR, compared to 30% with background retinopathy, 1% pre-proliferative 
retinopathy and 1% proliferative retinopathy. In the first postoperative visit, 19% of patients 
developed new DR compared to 70% stable and 11% improved. These proportions remained similar 
for each postoperative visit over time.  Young age, male gender, high pre-operative HbA1c and 
presence of pre-operative retinopathy were the significant predictors of worsening postoperatively.  
Conclusion 
Bariatric surgery does not prevent progression of DR. Young male patients with pre-existing DR and 
poor pre-operative glycaemic control are most at risk of progression. All diabetic patients should 
attend regular DR screening post bariatric surgery to allow early detection of potentially sight 
threatening changes, particularly among those with identifiable risk factors.  Future prospective 
studies with prolonged follow up are required to clarify the duration of risk.  
Key words: diabetic retinopathy, bariatric surgery, progression, sight threatening retinopathy, type 2 
diabetes, obesity 
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Introduction  1 
Bariatric surgery is becoming increasingly popular with the rising prevalence of obesity. With up to a 2 
quarter of the UK population affected by obesity1,  approximately 6000 bariatric operations are 3 
currently performed in the UK each year.2 Increasingly, bariatric surgery has been recognised not 4 
only as an effective treatment for achieving substantial sustained weight loss, but also in inducing 5 
significant and rapid glycaemic control resulting in remission of type 2 diabetes in approximately 6 
80% of cases within 2 years.3 Therefore NICE has recommended bariatric surgery as a treatment 7 
option for obese patients with type 2 diabetes who are refractory to other weight loss management 8 
options.4 In particular, NICE has recognised the benefit of bariatric surgery for obese patients with 9 
recent onset type 2 diabetes and recommend an expedited assessment to be offered to patients 10 
with recent onset type 2 diabetes even if their body mass index (BMI) is below the usual cut-off 11 
criteria.  12 
However, little is known about the effect of bariatric surgery on the diabetic microvascular 13 
complications such as diabetic retinopathy (DR). As observed during intensification of diabetes 14 
management in pregnancy5, initiation of insulin pumps6 and after pancreatic transplantation7, rapid 15 
improvement in glycaemic control may cause a paradoxical worsening in DR. Currently there is 16 
conflicting evidence on the evolution of DR post bariatric surgery. From case studies 8to short term 17 
retrospective studies9-13 and pilot prospective studies14-16, mixed results have been reported. The aim 18 
of our study was to provide clarification on the evolution of DR post bariatric surgery and report on 19 
the risk factors that may be associated with it.  20 
Subjects and Methods 21 
Record retrieval  22 
Under UK guidelines, the analysis was classified as a service evaluation and as such did not require 23 
ethical approval. The medical records of all diabetic patients receiving bariatric surgery and diabetes 24 
care at the Sunderland Specialist Bariatric Surgery Centre and Sunderland Diabetes Centre from 25 
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2009 to 2015 were identified by a prospectively collected electronic database. All patients were 26 
assessed by the diabetes team pre-operatively and a diagnosis of type 2 diabetes was confirmed. 27 
Demographic and clinical details including age, gender, type of bariatric surgery and duration of 28 
diabetes prior to surgery were extracted from the database for analysis. Immediate pre-operative 29 
and one year post-operative glycated haemoglobin level (HbA1c) and weight were also obtained. 30 
Annual DR screening results were extracted from local diabetic retinopathy screening service 31 
databases. The immediate pre-operative DR screening grade and annual DR grades following surgery 32 
were recorded using the National Screening Committee (NSC) Diabetic Retinopathy Grading system.  33 
Bariatric surgery provision  34 
Bariatric surgery is offered in the Sunderland Specialist Bariatric Surgery Centre as per NICE 35 
guidelines, for patients with a BMI >40 or BMI 35-40 and a serious health condition that could be 36 
improved if weight loss is achieved such as type 2 diabetes and hypertension.4 Furthermore, the 37 
patient must fulfil the following criteria: all appropriate non-surgical methods have failed to achieve 38 
or maintain a beneficial level of weight loss, the patient has received intensive multidisciplinary team 39 
management, the patient agrees to commit to long-term follow up treatment and he or she is fit for 40 
surgery.4  41 
Three main types of bariatric surgery are offered at Sunderland, all of which are usually performed 42 
laparoscopically: gastric banding, sleeve gastrectomy (both based on restriction), and gastric bypass 43 
(such as Roux-en-Y gastric bypass, mini loop gastric bypass) which uses a combination of restriction 44 
and malabsorption.17 Gastric balloon can be inserted endoscopically and is often used as an interim 45 
option to achieve target weight before laparoscopic surgery. 17 46 
 47 
Diabetic retinopathy screening  48 
Diabetic retinopathy screening in the study area was carried out on all diabetic patients over the age 49 
of 12 years by digital photography with pupillary dilatation according to nationally agreed 50 
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standards.18 Two 45 degree fundal field images are captured: one disc centred and one fovea 51 
centred.   Images are graded as per national guidelines, with an overall retinopathy grade and a 52 
maculopathy grade given for each eye.  The National Screening Committee (NSC) Diabetic 53 
Retinopathy Grading system includes the following: background (R1), pre-proliferative (R2) or 54 
proliferative retinopathy (R3); maculopathy as no maculopathy (M0) or evidence of maculopathy 55 
(M1). R2, R3 and M1 are regarded as referable grades to the hospital eye service and are termed 56 
sight threatening DR (STDR).18  57 
Inclusion criteria  58 
All patients with type 2 diabetes who underwent bariatric surgery between 2009 – 2015, with at 59 
least one available pre-operative and one post-operative retinal screening result were included.  60 
Patients with no available pre-operative or post-operative screening records for analysis were 61 
excluded. The Sunderland Bariatric Centre receives referrals from all over the North East region; we 62 
had access to the five major local screening service databases – Newcastle, Sunderland, County 63 
Durham and Darlington, South Tees, North Tees, therefore patients who were screened outside 64 
these centres were excluded due to inaccessible results.  65 
 66 
Statistical analysis 67 
Descriptive and statistical analyses were performed using Minitab 17 version 1.0. Continuous 68 
variables were presented as median and interquartile range. Categorical variables were presented as 69 
frequency and percentage. T-tests were used to compare continuous variables between groups, log 70 
transforming to produce approximate Normality if necessary. Categorical variables were compared 71 
between groups using a Chi squared test. Statistical significance was considered with a p-value of 72 
0.05 or less.  73 
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The retinal screening grades were coded as: R0, R1, R2, R3, M0, M1. As there was a limited number 74 
of patients who had higher grades of diabetic retinopathy, R1, R2, R3 were combined into one 75 
category for the purpose of analysis. McNemar’s test was performed to analyse the association 76 
between preoperative versus postoperative retinopathy and maculopathy status.  77 
Logistic regression was conducted to examine potential risk factors for the progression of diabetic 78 
retinopathy at the first postoperative visit, at any postoperative visit thereafter and at any 79 
postoperative visit. Both univariate and multivariate models were used to explore the predicted 80 
effect of the risk factors. The most important variables were selected using a stepwise procedure. 81 
Other variables that did not significantly improve the fit of the models were not included.  82 
 83 
Results 84 
Subject characteristics 85 
A total of 203 diabetic patients underwent bariatric surgery during 2009-2015. One-hundred-one 86 
patients were excluded due to unavailable pre-operative or postoperative DR screening results. 87 
Reasons include patients being screened outside of accessible local programs, and patients failing to 88 
attend screening, or death. Therefore a total of 102 patients were eligible for analysis. The 89 
characteristics of these patients are summarised in table 1. The median age was 55 years old and the 90 
majority were female (67%). The most common surgical procedure undertaken was Roux-en-Y 91 
gastric bypass (n=69, 67%), followed by sleeve gastrectomy (n=14, 14%), gastric band (n=12, 12%), 92 
mini bypass (n=4, 4%) and gastric balloon only (n=3, 3%). The median pre-operative HbA1c of our 93 
cohort was 61 mmol/mol with a median weight of 123 kg. The median duration of diabetes defined 94 
as the time in years from diagnosis to bariatric procedure was 6 years in our cohort.  95 
Following bariatric surgery, 86% of patients experienced an improvement in HbA1c. Median pre-96 
operative HbA1c was 61mmol/mol, there was a significant median reduction in HbA1c of 14 97 
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mmol/mol (p<0.001) or 26% (p<0.001), resulting in a median postoperative HbA1c of 45 mmol/mol. 98 
In our cohort, 42% achieved an HbA1c level <43 mmol/mol – the threshold defined as reversal of 99 
diabetes19, 20. There was no correlation between HbA1c changes (postop HbA1c, change in HbA1c, 100 
%change in HbA1c) and type of bariatric procedure undertaken (p=0.215, 0.324, 0.246 respectively). 101 
The medianweight postoperatively was 102 kg with a median weight loss of 22kg (18%).  102 
Diabetic retinopathy  103 
Prior to bariatric surgery, 68% of patients had no retinopathy, 30% had background retinopathy, 1% 104 
had pre-proliferative retinopathy and 1% had proliferative retinopathy. Ninety-four percent of 105 
patients had no maculopathy pre-operatively versus 6% with maculopathy. Three percent of patients 106 
had previous photocoagulation treatment.  107 
The median follow up was 4 years (interquartile range 2-5 years). Throughout the duration of follow 108 
up, 44% (n=45) of patients with no retinopathy, 25% (n= 26) of patients with background retinopathy 109 
and 1% (n=1) with proliferative retinopathy remained stable. At any post-op visit, 4% (n=4) of 110 
patients with background retinopathy experienced an improvement to no retinopathy. Twenty-four 111 
percent (n=24) of patients with no retinopathy experienced a progression to background 112 
retinopathy, 1% (n=1) of patients with background retinopathy and 1% (n=1) of patient with pre-113 
proliferative retinopathy progressed to proliferative retinopathy. The overall incidence of new 114 
retinopathy was therefore 24% (n=24). The preoperative retinopathy grades vs worst postoperative 115 
retinopathy grades detected at any postoperative visit are presented in Table 2.  116 
Regarding the evolution of maculopathy post-operatively, 88% (n=90) of patients with no 117 
maculopathy remained stable. Three percent (n=3) of patients with maculopathy improved to no 118 
maculopathy and 3% (n=3) remained the same. Incidence of new maculopathy was 6% (n=6). In 119 
particular a 46 years old man had background retinopathy in one eye and no maculopathy pre-120 
operatively developed bilateral maculopathy requiring treatment within two years of undergoing 121 
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bariatric surgery. This was associated with a rapid reduction in his HbA1c from 112 to 37 mmol/mol 122 
within 12 months (Figure 1).  123 
 124 
There was no significant change in the proportion of patients who worsen, remained stable or 125 
improved over the 4 years of follow up (p=0.91) – see Table 3. In the first postoperative year, 19% 126 
(n=18) patients worsened, 70% (n=66) patients were stable and 11% (n=10) patients improved. In 127 
the second year, 14% (n=10) patients worsen with 10% (n= 7) who maintained their deterioration 128 
from previous year, 68% (n=49) remained stable, 5% (n= 4) improved with 3% (n=2) maintaining 129 
their improvement. In the third year, 16% (n=9) patients worsened with 9% (n=5) maintained 130 
deterioration, 65% (n=36) stable and 4% (n=2) improved with 6% (n=3) maintained improvement. In 131 
the fourth year, 7% (n=4) worsened with 5% (n=3) maintained deterioration, 80% (n= 45) stable and 132 
4% (n=2) improved with 4% (n=2) maintained improvement. Overall, the incidence of worsening at 133 
any postoperative visit, irrespective of preoperative DR status is 25% (n=26) compared to 71% (n=72) 134 
remaining stable and 4% (n=4) experiencing improvement.    135 
 136 
Risk factors  137 
Age, gender, preoperative HbA1c, percentage change in HbA1c, preoperative retinopathy were the 138 
significant predictors included in the logistic regression model. Type of bariatric surgery and 139 
preoperative weight were not significantly associated with the outcome and therefore not included 140 
in the model. Change in weight, percentage change in weight and duration of diabetes diagnosis 141 
were correlated with the main key variables and were not found to be significant after allowance for 142 
the other variables in the multiple model. We found a high preoperative HbA1c was associated with 143 
a higher probability of worsening in either eye at any postop visit (p<0.001, ). For every 144 
1mmol/mol increase in preoperative Hba1c level above 53mmol/mol, the OR of worsening at any 145 
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visit was 1.07(95% CI 1.04, 1.11), p<0.001. A younger age and male gender were also associated with 146 
a greater risk of worsening at any visit (p<0.01; p<0.05 respectively). Features of patients who 147 
experienced progression vs those who remained stable or improved over follow up period are 148 
presented in Table 4.  149 
Significant predictors of progression at the first postoperative visit were preoperative HbA1c and age 150 
(both p<0.05). For every 1 year increase in age, this was associated with an OR of 0.93(95% CI 0.88, 151 
0.98), p=0.004. A small % change in HbA1c was not positively associated with worsening in the first 152 
visit but was for visits after that (p<0.001, ).  For every 1% change in postoperative HbA1c, 153 
the OR of worsening was 0.96(95% CI 0.94. 0.99), p<0.001. 154 
Presence of any retinopathy preoperatively (background, pre-proliferative or proliferative) was 155 
associated with a very high probability of either remaining in this category or progressing further 156 
during any postop visit (p<0.001). A similar trend was also found when analysing the effect of 157 
preoperative retinopathy grade on the first postoperative visit result (p = 0.07). The presence of 158 
existing maculopathy was not associated with increased chance of persisting maculopathy post-159 
surgery. 160 
There was no evidence of a change in the proportions of patients who improved, maintained 161 
improvement, stable, worsened and maintained stable over time (p=0.91).  162 
Discussion 163 
The results of our study, one of the largest to date, have shown that bariatric surgery does not 164 
guarantee improvement or prevention of DR, despite improved HbA1c in 86% of our patients and 165 
42% achieving normalised HbA1c. The incidence of developing new diabetic retinopathy at each 166 
postoperative visit ranged from 19% - 7%, with 10% - 5% of patients maintaining deterioration from 167 
previous screening. Whilst national screening guidelines exist, there is still limited awareness of the 168 
potential risk of DR progression postoperatively including patients achieving non-diabetic HbA1c 169 
levels and the need to continue regular screening; two patients within our cohort were discharged 170 
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from the DR screening service by their General Practitioner after bariatric surgery. Our study clearly 171 
shows that patients can continue to develop diabetic retinopathy post bariatric surgery, including 172 
potentially sight threatening maculopathy. Therefore our results support the current UK NHS 173 
diabetic eye screening programme recommendations that all patients should be screened annually if 174 
there has ever been a definite diagnosis of diabetes, even if they are in remission due to an 175 
intervention such as bariatric surgery. 21 176 
Our 1-year incidence of worsening of 19% was similar to the results described in the literature to 177 
date, where a wide range has been reported: 1% (n=63)13, 5% (n=56)15, 11% (n=56)16, 16% (n=318)10, 178 
18% (n=38)12, 18% (22)11, 45% (n=20)14. Kim et al reported the highest rate of progression so far in 179 
the literature; 45% in a cohort of 20 patients in a prospective pilot study.14 Other than the difference 180 
in study design, the pre-operative HbA1c in their cohort was much higher than our study (81 vs 65 181 
mmol/mol) and a different grading system was used which may contribute to the difference in 182 
results reported. Conversely, Miras et al13  reported a very low rate of 1% in a cohort of 67 patients 183 
in a prospective study, however HbA1c results were not reported and progression was defined as 184 
change in at least 2 steps in a different grading system. Moreover, many of these studies were 185 
limited in their small sample size and short follow up duration which further restricts direct 186 
comparisons.  187 
As expected, the presence of any retinopathy preoperatively predicted a high risk of either 188 
remaining in this category or progressing further during any postoperative visit. The other major risk 189 
factor associated with progression was a higher pre-operative HbA1c; every 1mmol/mol increase in 190 
preoperative Hba1c level above 53mmol/mol was associated with an OR 1.07(95% CI 1.04, 1.11), 191 
p<0.001. This was consistent with previous studies showing poor glycaemic control pre-operatively 192 
predicted a high risk of progression postoperatively.10 A younger age and male gender were also 193 
associated with a greater risk of worsening at any visit.  194 
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In regards to predicting acute progression after bariatric surgery, pre-operative HbA1c and young 195 
age are the significant factors correlating with progression at the first post-operative screening. For 196 
every 1 year increase in age, this was associated with OR 0.93(95% CI 0.88, 0.98), p=0.004. We did 197 
not find a large reduction in postoperative HbA1c was associated with a higher retinopathy grade in 198 
follow up as reported by Murphy et al.10 In fact, our results showed a small percentage change in 199 
HbA1c was not associated with worsening in the first postoperative visit but was associated with 200 
worsening in the visits after that. For every 1% change in postoperative HbA1c, the OR of worsening 201 
was 0.96(95% CI 0.94. 0.99), p<0.001. This suggests persistent hyperglycaemia is a predictor for 202 
progression and is consistent with large epidemiological studies showing poor glycaemic control is 203 
associated with DR progression over time in a non-bariatric surgical patient cohort.22 Our results 204 
suggest that patients with risk factors such as pre-existing DR, young age, male gender, a high 205 
preoperative HbA1c and failure to improve glycaemic control significantly postoperatively need to 206 
be closely followed up over time. In particular, young patients with a high preoperative HbA1c may 207 
require more intensive monitoring in the first year post surgery to allow early detection of potential 208 
acute progression.  209 
The type of bariatric surgery was not found to be significantly associated with a particular DR 210 
outcome. This may be due to the lack of correlation between changes in HbA1c (postoperative 211 
HbA1c, change in HbA1c, percentage change in HbA1c) and type of bariatric procedure undertaken 212 
(p=0.215, 0.324, 0.246 respectively). Similarly preoperative weight and change in weight 213 
postoperatively were also not significantly associated with worsening, having allowed for the key 214 
variables, which were similar to other study results9, 13 suggesting that metabolic control may be the 215 
main predictor of DR progression postoperatively.  216 
Furthermore, follow up over 4 years revealed that the proportion of patients experiencing 217 
worsening and maintaining deterioration were similar for each postoperative visit. This was in 218 
contrast to Murphy et al10 who reported increasing length of time postoperatively was related to a 219 
12 
 
lower probability of having a retinopathy grade of moderate or above. A potential explanation for 220 
this result is the idea of metabolic memory, in which the impact of hyperglycaemia in patients with 221 
type 2 diabetes mellitus before bariatric surgery persists for many years, despite the improvement in 222 
glucose metabolism observed post-surgery. Our results highlights the importance of continuing 223 
diabetic retinopathy screening post-bariatric surgery for at least 5 years, particularly among those 224 
with risk factors for worsening.  225 
We acknowledge that there are several limitations of this study. It was a retrospective study with 226 
limited collection of confounding variables such as blood pressure and nephropathy. A control group 227 
could also have strengthened this study, although a well-balanced or randomised design is difficult 228 
to achieve in bariatric surgery. It was also not possible to account for any potential pre-operative 229 
improvement in glycaemic control through medical management and diet restriction in preparation 230 
for surgery.  However many centres require a pre-operative weight loss23 and therefore our results 231 
extend to these settings. The strength of our study lies in its large cohort size with a prolonged 232 
follow up compared to existing studies. We examined a large number of variables to determine the 233 
risk factors for progression. We also used a robust grading scheme which was quality assured to NSC 234 
standards and 92% of our patients had complete data at 1 year of follow up.  235 
In conclusion, our study has shown that bariatric surgery does not guarantee or prevent progression 236 
of DR. Young male patients with pre-existing DR, poor pre-operative glycaemic control and who fail 237 
to improve HbA1c significantly postoperatively are most at risk of progression. Therefore based on 238 
our results, we recommend that all diabetic patients should attend regular DR screening post 239 
bariatric surgery to allow early detection of potentially sight threatening changes, particularly among 240 
those with identifiable risk factors.  Future prospective studies with prolonged follow up is required 241 
to further investigate risk factors as well as clarify appropriate screening intervals and duration of 242 
screening for patients after bariatric surgery.  243 
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Titles and legends to figures 
 
Figure 1 
 
Bilateral colour fundus photographs of a 46 years old man who developed new bilateral 
maculopathy 2 years post bariatric surgery despite improved HbA1c from 112 to 37 mmol/mol 
within 12 months. Top image showing right eye (blue circle indicating presence of intraretinal 
microvascular abnormalities); bottom image showing left eye.  
 
